SynthesisJournal of neurology2022

Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.

Jianian Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.